An Observational Study of Menopausal Symptom in Patients With

Status Recruiting

Clinical Trial Summary

Through long-term dynamic monitoring of gynecologic malignant tumor patients undergoing early menopause after ovaries resection in our center, we explored the changes in menopausal symptoms and bone health status of this population, and studied the effects of platinum combined chemotherapy drugs on menopausal symptoms and bone loss in gynecologic malignant tumor patients. To find the optimal time point and effective regimen for MHT in gynecologic malignancies undergoing surgical menopause, and to provide guidance for osteoporosis screening and prevention strategies in women with gynecologic cancer.

Clinical Trial Description

Gynecological malignancies are affecting the health of more and more women in the world, and the age of onset is also gradually younger. For women of reproductive age with gynecologic malignancies, surgery involving bilateral ovariectomy, followed by chemoradiotherapy or anti-estrogen therapy to maintain endocrine therapy, can lead to early menopause, leading to earlier and more severe menopausal syndrome and bone loss. Unlike the management of healthy women with natural menopause, the management of prognosis and quality of life in cancer patients with early menopause resulting from surgery combined with adjuvant therapy is more challenging and specific, and it is critical to identify management options for this complex patient population. This study aims to conduct long-term dynamic monitoring of patients with gynecologic malignancies undergoing early menopause after ovaries resection in our center, explore the changes in menopausal symptoms and bone health status of this population, and study the effects of platinum combined chemotherapy drugs on menopausal symptoms and bone loss in patients with gynecologic malignancies. To find out the best time point and effective program of menopausal hormone therapy for gynecological malignant tumor patients with surgical menopause, and provide guidance for osteoporosis screening and prevention strategies for women with gynecological cancer. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06151028
Study type	Observational
Source	Anhui Provincial Hospital
Contact	Ying Zhou, MD
Phone	+8613865901025
Email	caddiezy@ustc.edu.cn
Status	Recruiting
Phase
Start date	December 1, 2023
Completion date	December 31, 2033

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04043286` - The Effects of Dis/Reconnection of Implant Abutments on Peri-implant Bone Levels	N/A
Recruiting	`NCT03046147` - The Effect of Roux-en-Y Gastric Bypass on Bone Turnover	N/A
Completed	`NCT01292395` - Effects of Dietary Protein on Musculoskeletal Health During Calorie Deficiency	N/A
Completed	`NCT00485953` - Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy	Phase 4
Completed	`NCT00674453` - The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation	Phase 2
Completed	`NCT00181584` - Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer	Phase 2
Withdrawn	`NCT04380155` - Cycling Duration and Bone Markers in in Active Young Adults	N/A
Active, not recruiting	`NCT04779216` - Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa	Phase 3
Completed	`NCT05371418` - Comparative Clinical and Radiographical Evaluation of Treatment of Angular Bone Defect Related to Over Erupted Tooth Using GTR Followed by Orthodontic Intrusion Versus Orthodontic Intrusion Followed by GTR	N/A
Not yet recruiting	`NCT04345250` - Bone Response to Exercise and Energy Restriction in Young Adults	N/A
Active, not recruiting	`NCT05301400` - Marginal Bone Loss in Single Implant Restaurations With Different Methods	N/A
Active, not recruiting	`NCT05405894` - Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Recruiting	`NCT04983758` - 20-year Implant Survival in Periodontally Healthy and Compromised Patients
Recruiting	`NCT04713774` - Bone Density and Vascular Calcifications Evolution After Renal Transplant
Completed	`NCT04279392` - Healthy Body, Healthy Bones After Bariatric Surgery Trial	Phase 1/Phase 2
Completed	`NCT04332679` - Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes	N/A
Completed	`NCT05721014` - Effects of OsteoStrong vs. Individually Adapted and Combined Training on Bone Health	N/A
Recruiting	`NCT04883502` - Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs
Not yet recruiting	`NCT05066815` - Evaluation of Crestal Bone Loss Around Short Dental Implants As Affected By Two Suprastructure Materials	N/A
Completed	`NCT03292146` - Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

An Observational Study of Menopausal Symptom in Patients With Gynecological Malignancy After Oophorectomy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms